Pharmacy Medical News about Generics

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bioequivalence Criteria for Transdermal Fentanyl Generics: Do These Need a Relook
Clinical Pharmacokinetics, 09/30/09

Walter C et al. – Experimental or clinical evidence is required to provide the necessary database for final judgement of bioequivalent limits of fentanyl generics. At present, the evidence is not sufficient to advise other bioequivalence criteria than those previously applied to transdermal fentanyl.

<< Previous
Induction Chemotherapy with S-1 Plus Cisplatin Followed by...

Next >>
Sodium Channel Blockers for the Treatment of Neuropathic Pain

Mylans Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier
Mylan, 11/16/09 Relevance Score: 89%

Teva Receives Favorable Court Decision Regarding Generic Prevacid Solutab
Teva Pharmaceutical Industries, 11/11/09 Relevance Score: 87%

Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots
Diagnostic Microbiology and Infectious Disease, 10/22/09 Relevance Score: 87%

Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin
Current Medical Research and Opinion, 11/17/09 Relevance Score: 85%

Use and cost of branded and generic drugs in patients with coronary heart disease-results from a prospective survey of 1008 patients in two London hospitals
QJM: An International Journal of Medicine, 10/16/09 Relevance Score: 84%